GlassScriptPhysician profile
Camilo A Paredes
NPI 1124342316
$8,519.03
in general payments reported to CMS, 2019-2025
48 companies · $843 in 2025
The $843 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,542 · 2022: $1,856 · 2023: $1,837 · 2024: $1,441 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,121.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,753.34 | 2021-2025 | |
| Novo Nordisk INC | $1,095.65 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $612.99 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $556.87 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $531.50 | 2021-2025 | Otezla, Repatha, Otezla |
| Esperion Therapeutics, INC. | $456.03 | 2021-2024 | Nexletol |
| Abbott Laboratories | $338.63 | 2021-2025 | Freestyle Libre 3, Id Now Instrument |
| Boehringer Ingelheim Pharmaceuticals, INC. | $330.61 | 2021-2025 | Jardiance, Synjardy |
| Amarin Pharma, INC. | $223.14 | 2021-2022 | |
| Corcept Therapeutics | $216.93 | 2024-2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $207.91 | 2021-2024 | Trulance, Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $190.04 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $176.95 | 2021-2023 | Belsomra, Pneumovax 23, Vaxneuvance |
| Pfizer INC. | $169.91 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $163.40 | 2021-2025 | Farxiga |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Camilo Paredes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.